TN SB0421 | 2025-2026 | 114th General Assembly
Status
Spectrum: Partisan Bill (Republican 1-0)
Status: Introduced on January 28 2025 - 25% progression
Action: 2025-02-19 - Placed on Senate Judiciary Committee calendar for 2/25/2025
Pending: Senate Judiciary Committee
Hearing: Feb 25 @ 3:00 pm in Cordell Hull Building
Text: Latest bill text (Draft #2) [PDF]
Status: Introduced on January 28 2025 - 25% progression
Action: 2025-02-19 - Placed on Senate Judiciary Committee calendar for 2/25/2025
Pending: Senate Judiciary Committee
Hearing: Feb 25 @ 3:00 pm in Cordell Hull Building
Text: Latest bill text (Draft #2) [PDF]
Summary
As introduced, authorizes certain prescribing physician assistants and nurse practitioners to prescribe buprenorphine products for the treatment of opioid use disorder when the physician assistant or nurse practitioner is employed by or contracts with a state correctional facility or county or municipal jail, and certain other conditions are met. - Amends TCA Title 33; Title 41; Title 53 and Title 63.
Title
AN ACT to amend Tennessee Code Annotated, Title 33; Title 41; Title 53 and Title 63, relative to healthcare prescribers.
Sponsors
History
| Date | Chamber | Action |
|---|---|---|
| 2025-02-19 | Senate | Placed on Senate Judiciary Committee calendar for 2/25/2025 |
| 2025-02-12 | Senate | Passed on Second Consideration, refer to Senate Judiciary Committee |
| 2025-02-10 | Senate | Introduced, Passed on First Consideration |
| 2025-01-28 | Senate | Filed for introduction |
Same As/Similar To
HB1239 (Crossfiled) 2025-02-12 - Assigned to s/c Health Subcommittee
